Literature DB >> 32974810

Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.

Aikaterini E Micha1, Victoria Sinnett1, Kate Downey1,2, Steve Allen1,2, Briony Bishop2,3, Lauren R Hector1, Elaine P Patrick1, Ruth Edmonds2, Peter A Barry1,4, Katherine D C Krupa1, Jennifer E Rusby5,6.   

Abstract

BACKGROUND: Guide-wire localisation remains the most commonly used technique for localisation of impalpable breast lesions in the UK. One alternative is magnetic seed localisation. We aimed to investigate patient and clinician satisfaction in two consecutive cohorts, describe re-excision and positive margin rates, and explore reasons for positive margins and the implications for localisation techniques.
METHODS: A single-institution prospective service evaluation of two cohorts of consecutive cases of wire and then Magseed localisation was carried out. Data were collected on patient and clinician satisfaction, clinico-pathological findings, and causes of involved margins. T tests were used to compare continuous variables and Chi-squared test for satisfaction outcomes.
RESULTS: 168 consecutive cases used wire-guided localisation (WGL) and 128 subsequent cases used Magseeds. Patients reported less anxiety between localisation and surgery in the Magseed group, and clinicians reported greater ease of use of Magseeds. There were no differences in lesion size, surgical complexity, or re-excision rate between the groups. In a subset of patients receiving standard wide local excision (i.e., excluding mammoplasties), the impact on margin involvement was investigated. There was no significant difference in radiological under-sizing or accuracy of localisation. However, specimen weight and eccentricity of the lesion were statistically significantly lower in the Magseed group. Despite this, re-excision rates were not significantly different (p = 0.4).
CONCLUSIONS: This is the first large study of satisfaction with localisation and showed clinician preference for Magseed and a reduction in patient anxiety. It also demonstrated similar positive margin rates despite smaller specimen weights in the Magseed group. Magnetic seed localisation offers an acceptable clinical alternative to guide wire localisation. The impact on local service provision should also be considered.

Entities:  

Keywords:  Breast cancer; Localisation; Magnetic seed; Magseed; Wide local excision

Mesh:

Year:  2020        PMID: 32974810      PMCID: PMC7796883          DOI: 10.1007/s12282-020-01149-1

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  17 in total

1.  A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.

Authors:  Abdi-Fatah Hersi; Staffan Eriksson; Joakim Ramos; Shahin Abdsaleh; Fredrik Wärnberg; Andreas Karakatsanis
Journal:  Eur J Surg Oncol       Date:  2018-10-23       Impact factor: 4.424

2.  Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.

Authors:  Konstantinos Zacharioudakis; Sue Down; Zaheerah Bholah; Sum Lee; Taherah Khan; Anthony J Maxwell; Miles Howe; James Harvey
Journal:  Eur J Surg Oncol       Date:  2019-06-26       Impact factor: 4.424

Review 3.  Implementing the SAVI SCOUT System in Community Radiology Practice.

Authors:  Megan Kalambo; Jay R Parikh
Journal:  J Am Coll Radiol       Date:  2017-06-16       Impact factor: 5.532

4.  Evaluation of a Nonradioactive Magnetic Marker Wireless Localization Program.

Authors:  Leslie R Lamb; Manisha Bahl; Michelle C Specht; Helen Anne D'Alessandro; Constance D Lehman
Journal:  AJR Am J Roentgenol       Date:  2018-08-07       Impact factor: 3.959

5.  Simultaneous use of magnetic method in localization of impalpable breast cancer and sentinel lymph nodes detection: initial experience.

Authors:  Kamil Pohlodek; Martin Foltín; Iveta Mečiarová; František Ondriaš
Journal:  Nanomedicine (Lond)       Date:  2018-11-15       Impact factor: 5.307

6.  Transection of the localization hooked wire during breast biopsy.

Authors:  M J Homer
Journal:  AJR Am J Roentgenol       Date:  1983-11       Impact factor: 3.959

7.  Evaluation of the SAVI SCOUT Surgical Guidance System for Localization and Excision of Nonpalpable Breast Lesions: A Feasibility Study.

Authors:  Victoria Mango; Richard Ha; Ameer Gomberawalla; Ralph Wynn; Sheldon Feldman
Journal:  AJR Am J Roentgenol       Date:  2016-06-15       Impact factor: 3.959

8.  A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.

Authors:  Charles E Cox; Scott Russell; Vanessa Prowler; Ebonie Carter; Abby Beard; Ankur Mehindru; Peter Blumencranz; Kathleen Allen; Michael Portillo; Pat Whitworth; Kristi Funk; Julie Barone; Denise Norton; Jerome Schroeder; Alice Police; Erin Lin; Freddie Combs; Freya Schnabel; Hildegard Toth; Jiyon Lee; Beth Anglin; Minh Nguyen; Lynn Canavan; Alison Laidley; Mary Jane Warden; Ronald Prati; Jeff King; Steven C Shivers
Journal:  Ann Surg Oncol       Date:  2016-07-28       Impact factor: 5.344

9.  Feasibility of magnetic marker localisation for non-palpable breast cancer.

Authors:  B Schermers; J A van der Hage; C E Loo; M T F D Vrancken Peeters; H A O Winter-Warnars; F van Duijnhoven; B Ten Haken; S H Muller; T J M Ruers
Journal:  Breast       Date:  2017-03-07       Impact factor: 4.380

Review 10.  Preoperative localization and surgical margins in conservative breast surgery.

Authors:  F Corsi; L Sorrentino; D Bossi; A Sartani; D Foschi
Journal:  Int J Surg Oncol       Date:  2013-08-05
View more
  1 in total

1.  Reflector-Guided Localisation of Non-Palpable Breast Lesions: A Prospective Evaluation of the SAVI SCOUT® System.

Authors:  Umar Wazir; Iham Kasem; Michael J Michell; Tamara Suaris; David Evans; Anmol Malhotra; Kefah Mokbel
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.